The global sternal closure systems market size was estimated at USD 2.05 billion in 2018 and is expected to witness a CAGR of 5.4% during the forecast period. Expanding the base of the geriatric population undergoing open-heart surgery through median sternotomy is considered to be one of the primary growth stimulants for the market. Median sternotomy procedure has remained the most popular technique for cardiac exposure to date, owing to easy and quick access to heart valves and vessels. Sternotomy and sternal closure occur prior and post-cardiac surgery, respectively.
Furthermore, developing countries are focusing on investing in public healthcare infrastructure due to rising non-communicable disease burden and injuries. This is projected to increase the number of surgical procedures in developing regions as well. According to data published by the World Bank, in 2015, China's per capita healthcare expenditure was USD 425.6, accounting for 5.3% of GDP. Furthermore, Plan of Health China 2030 estimates that by 2020 healthcare spending is anticipated to account for 6.5% to 7% of its total GDP. Sedentary lifestyles, high smoking, and alcohol consumption, and an unhealthy diet are leading to an increase in the prevalence of cardiac diseases globally. This is resulting in a rise in surgical procedures, which in turn, is likely to fuel the adoption of sternal closure systems in surgeries over the coming years. According to a survey conducted by the Centers for Disease Control and Prevention, in 2016, 28.1 million adults in the U.S. were diagnosed with heart disease.
A rise in the number of surgical procedures globally has driven demand for surgical instruments leading to the growth of the market. According to OECD, the estimated surgical procedures in 2012, were around 399,952 in the U.K. which later increased to 491,604 by 2016. Furthermore, lack of exercise and poor nutrition increase the risk of heart diseases in the elderly population. Furthermore, the growing geriatric population, which is more susceptible to chronic CVDs, is leading to an increase in the number of cardiovascular surgical procedures, thereby boosting the demand for sternal closure systems globally.
Moreover, developing countries are focusing on investing in public healthcare infrastructure due to the rise in non-communicable disease burden and injuries will further increase the number of surgical procedures in developing regions as well. According to data published by the world bank, in 2015, China's per capita healthcare expenditure was USD 425.6 accounting for 5.3% of GDP. Furthermore, Plan of Health China 2030 estimates that by 2020 healthcare spending is expected to account for 6.5% to 7% of its total GDP.
Based on the product, the market is bifurcated into closure devices and bone cement. Closure devices represented the leading share in the market in 2018. Factors such as the launch of products coupled with rising per capita expenditure in developed as well as developing economies are key factors responsible for the dominant share of the segment. These devices have demonstrated benefits such as a decrease in postoperative complications and infections along with faster recovery time in comparison with bone cement. Moreover, rising efforts being taken by key players in the market to introduce new techniques and product lines are likely to further boost the segment growth shortly.
Key products in this segment include SternaLock Blu and SternaLock 360 by Zimmer Biomet; Sternal ZIPFIX System by DePuy Synthes; and Sternal Talon Implants by KLS Martin Group. Companies operating in the market are focusing on R&D to deliver advanced solutions. For instance, Orthofix Holdings, Inc., a U.S. based company engaged in R&D and marketing of orthopedic products, has invested USD 28.8 million and USD 29.7 million during FY 2017 and FY 2018, respectively. In January 2017, JACE Medical, LLC has launched pre-monoblock sternal plates in the U.S. These plates are used before the surgery and work as implant positioner.
Some of the materials used for sternal closure systems are titanium, PEEK, and stainless steel. Titanium material accounted for over 40.0% of the total market share in 2018. This dominance is due to the associated benefits such as corrosion-resistant, ability to effectively join human bones, and biocompatibility of titanium. Besides, non-ferromagnetic property, which allows patients with titanium implants to examine safely under Magnetic resonance imaging (MRI) scan, is further enhancing penetration of this material in the industry.
Furthermore, high efficacy, non-toxic nature of implant and stability of the titanium products, greater economic feasibility coupled with increased affordability for the use of advanced titanium clips and plates in developed as well as developing region, are projected to bolster the penetration of titanium-based sternal closure systems. The Polyether Ether Ketone (PEEK) segment is expected to grow at the highest rate over the forecast period owing to technological advancements, growing R&D investments by key players, and biocompatible properties of the material.
The median sternotomy procedures dominated the procedure segment of the global sternal closure systems market with around 50.0% of share in 2018. Median sternotomies are frequently performed osteotomies worldwide, as the procedure provides easy access to the heart, lungs, and surrounding structures during heart valve replacement surgery and coronary artery bypass surgery. Median sternotomies also reduce post-operative infections and complications thereby further increasing its demand globally.
The growing geriatric population, prone to develop chronic cardiac disorders such as CVDs is anticipated to fuel demand for median sternotomy procedures. The geriatric population worldwide is anticipated to double in near future. According to a report by the United Nations Department of Economic and Social Affairs (2015), the number of people aged over 60 years is expected to grow by 56% from 2015 to 2030. The geriatric population was 901 million in 2015 and anticipated to reach 2.1 billion by 2050.
North America accounted for a dominant share of the global sternal closure systems market. Rising collaborative efforts commenced by key players to improve their product offerings and ensure high-quality standards is further anticipated to boost the demand for systems across the region. For instance, in August 2017, A&E Medical Corporation acquired RTI Surgical’s Cardiothoracic Closure business. RTI Surgical’s Cardiothoracic Closure business offers cable-based plate products such as Tritium SPC System. Moreover, the major share for North America can also be attributed to the high cardiac disease burden in this region. For instance, according to the study conducted by the CDC, around 28.1 million people in the U.S. have diagnosed with heart-related disorders such as cardiac arrest and valvular heart disease. Also, favorable reimbursement regulations are expected to further fuel the growth of the market. As per the revised wound closure Medicare reimbursement coding guide, sternal closure procedures are reimbursed under 216, 217, 218, 219, 220, 221, 228, and 229 MS-DRG codes from 2018.
On the other hand, Asia Pacific is expected to grow at a lucrative CAGR over the coming years as key players are increasing their geographical presence in the region and focusing on the commercialization of their product at a relatively affordable price. For instance, in June 2016, the KLS Martin Group started its operations in Chennai, India in an attempt to seize the growing opportunity. Moreover, growing healthcare expenditure and infrastructure facilities coupled with growing awareness about cardiac diseases and treatment availability will further fuel growth in the region.
Johnson & Johnson, Zimmer Biomet, B. Braun Melsungen AG, Orthofix Holdings, Inc. are some of the key players in the global market focusing on high R&D investment to deliver technically advanced product portfolio. For instance, Orthofix Holdings, Inc, a U.S. based company, which delivers CONSTRUX Mini PEEK Spacer System in the U.S. As a percentage of revenue, the company invested USD 29.7 million i.e. around 7.0% of its total revenue in research and development during FY 2017. Moreover, in 2017, the company has introduced 20 new products in the orthopedics, sternal closure, biologics, and spine fixation markets.
Merger and acquisition and product portfolio expansion are key strategies adopted by the industry players. For instance, in June 2017, DePuy Synthes, a subsidiary of Johnson and Johnson has acquired Innovative Surgical Solutions, LLC, a Michigan, U.S. based company. The acquisition was in a view to strengthen the company’s spine care solution product portfolio.
The base year for estimation
Actual estimates/Historical data
2015 - 2018
2019 - 2026
Revenue in USD Million and CAGR from 2019 to 2026
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
U.S., Canada, Germany, U.K., France, Spain, Italy, Japan, China, India, Brazil, Mexico, Argentina, Colombia, South Africa, Saudi Arabia, UAE
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2015 to 2026. For this study, Grand View Research has segmented the global sternal closure systems market report based on product, material, procedure, and region:
Product Outlook (Revenue, USD Million, 2015 - 2026)
Sternal Closure Wires
Sternal Closure Plates and Screws
Sternal Closure Clips
Sternal Closure Cables
Material Outlook (Revenue, USD Million, 2015 - 2026)
Polyether Ether Ketone (PEEK)
Procedure Outlook (Revenue, USD Million, 2015 - 2026)
Regional Outlook (Revenue, USD Million, 2015 - 2026)
Middle East & Africa
b. The global sternal closure systems market size was estimated at USD 2,157.7 million in 2019 and is expected to reach USD 2,270.1 million in 2020.
b. The global sternal closure systems market is expected to grow at a compound annual growth rate of 5.5% from 2019 to 2026 to reach USD 3.12 billion by 2026.
b. North America dominated the sternal closure systems market with a share of 34.8% in 2019. This is attributable to rising collaborative efforts commenced by key players to improve their product offerings and ensure high-quality standards.
b. Some key players operating in the sternal closure systems market include Depuy Synthes, Zimmer Biomet, KLS Martin Group, Orthofix Holdings, Inc.,A&E Medical Corporation, Jace Medical, LLC, Acute Innovations, Abyrx, Inc., Kinamed Incorporated.
b. Key factors that are driving the market growth include an increase in the number of surgical procedures and technological advancements in sternotomy techniques.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.